121 related articles for article (PubMed ID: 9226165)
1. Identification of increased protein tyrosine phosphatase activity in polycythemia vera erythroid progenitor cells.
Sui X; Krantz SB; Zhao Z
Blood; 1997 Jul; 90(2):651-7. PubMed ID: 9226165
[TBL] [Abstract][Full Text] [Related]
2. PTP-MEG2 is activated in polycythemia vera erythroid progenitor cells and is required for growth and expansion of erythroid cells.
Xu MJ; Sui X; Zhao R; Dai C; Krantz SB; Zhao ZJ
Blood; 2003 Dec; 102(13):4354-60. PubMed ID: 12920026
[TBL] [Abstract][Full Text] [Related]
3. Polycythemia vera. V. Enhanced proliferation and phosphorylation due to vanadate are diminished in polycythemia vera erythroid progenitor cells: a possible defect of phosphatase activity in polycythemia vera.
Dai CH; Krantz SB; Sawyer ST
Blood; 1997 May; 89(10):3574-81. PubMed ID: 9160662
[TBL] [Abstract][Full Text] [Related]
4. Defective expression of the SHP-1 phosphatase in polycythemia vera.
Wickrema A; Chen F; Namin F; Yi T; Ahmad S; Uddin S; Chen YH; Feldman L; Stock W; Hoffman R; Platanias LC
Exp Hematol; 1999 Jul; 27(7):1124-32. PubMed ID: 10390187
[TBL] [Abstract][Full Text] [Related]
5. The gene encoding hematopoietic cell phosphatase (SHP-1) is structurally and transcriptionally intact in polycythemia vera.
Asimakopoulos FA; Hinshelwood S; Gilbert JG; Delibrias CC; Göttgens B; Fearon DT; Green AR
Oncogene; 1997 Mar; 14(10):1215-22. PubMed ID: 9121771
[TBL] [Abstract][Full Text] [Related]
6. Increased erythropoiesis in polycythemia vera is associated with increased erythroid progenitor proliferation and increased phosphorylation of Akt/PKB.
Dai C; Chung IJ; Krantz SB
Exp Hematol; 2005 Feb; 33(2):152-8. PubMed ID: 15676208
[TBL] [Abstract][Full Text] [Related]
7. In vitro expansion of erythroid progenitors from polycythemia vera patients leads to decrease in JAK2 V617F allele.
Gaikwad A; Nussenzveig R; Liu E; Gottshalk S; Chang K; Prchal JT
Exp Hematol; 2007 Apr; 35(4):587-95. PubMed ID: 17379069
[TBL] [Abstract][Full Text] [Related]
8. [Effect of bloodletting on the proliferative activity of erythroid progenitor cells from the bone marrow of patients with polycythemia and polycythemia vera].
Hansz J; Kozłowska-Skrzypczak M
Pol Arch Med Wewn; 1991 Sep; 86(3):125-31. PubMed ID: 1808597
[TBL] [Abstract][Full Text] [Related]
9. Circulating erythroid progenitors in polycythemia vera are hypersensitive to insulin-like growth factor-1 in vitro: studies in an improved serum-free medium.
Correa PN; Eskinazi D; Axelrad AA
Blood; 1994 Jan; 83(1):99-112. PubMed ID: 8274756
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of the substance P and its derivative on erythropoietin-independent growth of erythroid progenitors in polycythemia vera.
Le Gall C; Ianotto JC; Hardy E; Ugo V; Eveillard JR; Ngo-Sack F; Bourquard P; Morice P; Berthou C
Leuk Res; 2008 May; 32(5):743-54. PubMed ID: 17980427
[TBL] [Abstract][Full Text] [Related]
11. Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera.
Ugo V; Marzac C; Teyssandier I; Larbret F; Lécluse Y; Debili N; Vainchenker W; Casadevall N
Exp Hematol; 2004 Feb; 32(2):179-87. PubMed ID: 15102479
[TBL] [Abstract][Full Text] [Related]
12. Polycythemia vera. II. Hypersensitivity of bone marrow erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells to interleukin-3 and granulocyte-macrophage colony-stimulating factor.
Dai CH; Krantz SB; Dessypris EN; Means RT; Horn ST; Gilbert HS
Blood; 1992 Aug; 80(4):891-9. PubMed ID: 1498332
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of JAK2-driven erythroid differentiation of polycythemia vera progenitors.
Geron I; Abrahamsson AE; Barroga CF; Kavalerchik E; Gotlib J; Hood JD; Durocher J; Mak CC; Noronha G; Soll RM; Tefferi A; Kaushansky K; Jamieson CH
Cancer Cell; 2008 Apr; 13(4):321-30. PubMed ID: 18394555
[TBL] [Abstract][Full Text] [Related]
14. Anti-erythropoietin (EPO) receptor monoclonal antibodies distinguish EPO-dependent and EPO-independent erythroid progenitors in polycythemia vera.
Fisher MJ; Prchal JF; Prchal JT; D'Andrea AD
Blood; 1994 Sep; 84(6):1982-91. PubMed ID: 8081000
[TBL] [Abstract][Full Text] [Related]
15. Erythropoiesis in polycythemia vera is hyper-proliferative and has accelerated maturation.
Bruchova H; Yoon D; Agarwal AM; Swierczek S; Prchal JT
Blood Cells Mol Dis; 2009; 43(1):81-7. PubMed ID: 19264517
[TBL] [Abstract][Full Text] [Related]
16. The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera.
Dupont S; Massé A; James C; Teyssandier I; Lécluse Y; Larbret F; Ugo V; Saulnier P; Koscielny S; Le Couédic JP; Casadevall N; Vainchenker W; Delhommeau F
Blood; 2007 Aug; 110(3):1013-21. PubMed ID: 17389763
[TBL] [Abstract][Full Text] [Related]
17. Endogenous erythroid colony assay in patients with polycythemia vera and its clinical significance.
Bai J; Shao ZH; Liu H; Shi J; He GS; Cao YR; Cui ZZ; Wu YH; Sun J; Tian Z; Jia HR; Qian LS; Yang TY; Yang CL
Chin Med J (Engl); 2004 May; 117(5):668-72. PubMed ID: 15161531
[TBL] [Abstract][Full Text] [Related]
18. Polycythaemia vera. IV. Specific binding of stem cell factor to normal and polycythaemia vera highly purified erythroid progenitor cells.
Dai CH; Krantz SB; Koury ST; Kollar K
Br J Haematol; 1994 Nov; 88(3):497-505. PubMed ID: 7529530
[TBL] [Abstract][Full Text] [Related]
19. Endogenous BFU-E in peripheral blood in diagnosis of polycythemia vera.
Biljanović-Paunović L; Ruvidić R; Pavlović-Kentera V
Eur J Haematol; 1990 Nov; 45(5):262-6. PubMed ID: 2261952
[TBL] [Abstract][Full Text] [Related]
20. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.
Michiels JJ; Juvonen E
Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
